Press Releases



Dec 20, 2007
Merck Serono and Flamel to Collaborate on an Extended Release Formulation for Therapeutic Proteins

Oct 30, 2007
Flamel Technologies Announces Third Quarter Results; Further Medusa Portfolio Expansion; and Stronger Coreg Revenues

Oct 25, 2007
Flamel Technologies Announces Positive Top Line Results of a Clinical Trial of IFN-alpha-XL versus PegIntron™ in Patients with Chronic Hepatitis C Virus Infection

Oct 18, 2007
Flamel Technologies Announces Positive Results of a Phase I Trial of FT-105 Basal Insulin versus Lantus®

Sep 12, 2007
Flamel Technologies Announces Medusa® License Agreement with Wyeth Pharmaceuticals

Aug 01, 2007
Flamel Technologies Announces Second Quarter Results, New Medusa Relationships, and Ongoing Work on COREG CR®

Jul 26, 2007
Flamel Technologies Announces Projected Release Date of Second Quarter Results, Conference Call

May 15, 2007
Flamel Technologies Announces Results of Annual Meeting

May 07, 2007
Flamel Technologies Announces First Quarter Results; COREG CR™ Launch; and Strong Sales of Product to GSK

Apr 30, 2007
Flamel Technologies Announces Projected Release Date of First Quarter Results, Conference Call

Mar 23, 2007
Flamel Technologies Welcomes Nationwide Availability of COREG CR™

Mar 07, 2007
Flamel Technologies Announces Fourth Quarter and Year-End Results

Mar 01, 2007
Flamel Technologies Announces Projected Release Date of Fourth Quarter and Annual Results, Conference Call